Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

November 01, 1999; 53 (8) Articles

Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis

S. Pradhan, N. Pandey, S. Shashank, R.K. Gupta, A. Mathur
First published November 1, 1999, DOI: https://doi.org/10.1212/WNL.53.8.1781
S. Pradhan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Pandey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Shashank
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.K. Gupta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Mathur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis
S. Pradhan, N. Pandey, S. Shashank, R.K. Gupta, A. Mathur
Neurology Nov 1999, 53 (8) 1781; DOI: 10.1212/WNL.53.8.1781

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
3

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Objective: To study the clinical correlates of lesions seen predominantly in the substantia nigra in some patients with Japanese encephalitis (JE).

Background: JE typically involves thalamus, brainstem, spinal cord, and cerebral cortex. Rarely, basal ganglia and cerebellum may be affected. Lesions are often widespread and discrete. Predominant involvement of substantia nigra in JE has not been previously reported.

Methods: Of 52 patients with JE seen in an endemic zone, five were selected on the basis of isolated lesions in the substantia nigra on MRI; all were subjected to detailed clinical and laboratory evaluation.

Results: Presenting symptoms were fever, alteration of consciousness, neck stiffness, and decreased body movements. Examination during acute illness revealed restricted eye movements, opsoclonus, upbeating nystagmus, and cogwheel rigidity. There was early and complete recovery of consciousness and eye signs. Parkinsonian features such as positive glabellar tap sign, masklike face, bradykinesia, tremors, and postural instability became apparent as these patients started walking. Reversible mutism was observed in three patients during the acute phase. Response to levodopa, amantadine, and trihexiphenedyl was partial. Three patients were followed for more than 1 year, during which time their parkinsonian features recovered completely. Substantial recovery was also observed in the two other patients 2 months after regaining consciousness.

Conclusions: Some patients with Japanese encephalitis may have lesions predominantly in the substantia nigra. After recovery from acute encephalitic illness, they manifest clinically with typical parkinsonian features. Although several viruses are known to cause parkinsonism, this is the first demonstration of a virus producing lesions predominantly in the substantia nigra and causing parkinsonism.

Japanese encephalitis (JE) is the most common endemic encephalitis reported from China, Southeast Asia, India, and Japan.1 Diagnosis is established by demonstrating fourfold or more than fourfold rise in titers against JE virus in convalescent serum as compared with acute serum.2,3 In the CNS, JE virus predominantly affects thalamus,4,5 brainstem,4,5 anterior horn cells of the spinal cord,6,7 and cerebral cortex.4 Symmetric or asymmetric lesions have also been observed in cerebellum and basal ganglia.4 Owing to the involvement of thalamus, basal ganglia, and their connections, various types of movement disorders have been described in relation to JE. Among them, tremors, dystonia, and choreoathetoid movements are the most common.8 Parkinsonian features have been described in JE virus–infected Fischer rats.9 In human beings, parkinsonism manifests rarely, as other extrapyramidal features usually predominate. Despite the involvement of substantia nigra, patients may not develop parkinsonism if concomitant lesions are seen in the thalamus.10 Our experience with MRI suggests midbrain lesions to be the second most common location after thalamus. However, the lesions in the midbrain are diffuse and often associated with lesions elsewhere in the CNS.

In the last 6 years, we examined five patients with JE with isolated lesions in the substantia nigra as seen on MRI. We describe the clinical details of these patients as they provide extremely rare evidence of a viral infection causing parkinsonism due to lesions predominantly in the substantia nigra.

Patients and methods.

Of 52 patients with JE seen over the course of 6 years, five were found on MRI to have selective involvement of substantia nigra. All patients lived in the northeastern districts of Uttar Pradesh (a province of India) near its border with Nepal. JE is known to be endemic in this region.11 This is perhaps a result of yearly postsummer floods in the tributaries of river Ganga (Ganges) and subsequent mosquito breeding in the adjacent rice fields. Of the 52 patients, 43 (including the five described here) were observed between the months of September and February. Diagnosis was confirmed in all five patients based on high immunoglobulin (Ig)M and IgG titers against JE virus as measured by hemagglutination inhibition (HI) test. The HI antibodies were estimated by the technique of Clarke and Casals,12 using a microtiter method.13 The method estimates combined IgG and IgM titers. Generally, fourfold or more than fourfold rise in HI antibody titers in the convalescent phase of illness as compared with the acute phase is considered diagnostic of JE. However, this criterion is somewhat arbitrary, and most studies from this endemic zone have included patients with more than threefold rise in titers as of diagnostic significance.3,14 The convalescent phase study was carried out after about 10 days of the acute phase study. One patient was first examined after the acute phase was over. His blood was also examined for HI antibodies after 10 months of acute illness to look for any delayed decline in titers against JE. Blood and CSF PCR studies were done to exclude herpes simplex and measles encephalitis. CSF was also examined to exclude pyogenic, tubercular, and fungal meningitis. Blood smears were examined on two occasions in all patients to exclude cerebral malaria. Detailed clinical examination was carried out in all patients during acute illness and during convalescence. Three patients were followed for 1 year and two patients for about 2 months.

MRI was performed on a 1.5-T superconducting unit (Siemens; Magnetom, Germany) using a circularly polarized head coil. T2 (repetition time [TR]/echo time [TE]/n = 2200/20/1), T1 (TR 1000/TE 14/n = 3), and magnetization transfer (MT) T1 (TR 1000/TE 14/n = 3)–weighted imaging was done with off-resonance presaturation. Postcontrast MT–T1-weighted imaging was also performed in axial plane in all cases. The imaging was done using 5-mm slice thickness, 0.5-mm interslice gap, and 192 × 256 matrix. For contrast study, Gd-DTPA was injected intravenously in a dose of 0.1 mmol/Kg of body weight. In one patient, T2-weighted sagittal image was also obtained to determine the precise extent of the lesion.

Results.

Clinical, laboratory, and neuroradiologic findings of the five patients are summarized in the table. There were three boys and two girls. Their ages ranged between 7 and 16 years. At the onset of illness, all patients had fever and headache; three of them also had rigors. Two patients had generalized tonic-clonic seizures. Three patients had mildly altered consciousness that developed 3 to 5 days after the onset of fever; two remained conscious throughout their illness. From the beginning of illness or on regaining consciousness, all patients manifested with mutism that lasted several weeks. Later on, when they spoke, they had a very low volume, monotonous but fluent speech. All five patients had decreased movements of the body. Four of them preferred to remain quiet and static; one was irritable and constantly moving around.

View this table:
  • View inline
  • View popup
Table 1.

Clinical, laboratory, and radiologic features in patients with Japanese encephalitis with isolated involvement of substantia nigra

Examination findings included restricted extraocular movements in all directions (three patients), upbeating nystagmus (two patients), and opsoclonus (one patient). Each of the five patients had parkinsonian features in different combinations (see the table). Drooling of saliva was observed in three, palmomental reflex in two, and glabellar-tap sign in two patients. All the patients had cogwheel rigidity; four of them had lead pipe rigidity as well. Three patients had tremors at rest, one of them having typical pill rolling tremors.

In all five patients, MRI revealed hyperintensities in the substantia nigra on T2-weighted images that appeared hypointense on T1. MT–T1-weighted images defined the boundary of the lesion as hyperintense with central isointensity. Postcontrast study did not show any abnormal enhancement. All the patients showed normal signals in the rest of the brain parenchyma.

Three patients were followed for 1 year, during which time they recovered completely. Tremors were the earliest to resolve (1 to 4 months) followed by cogwheel rigidity (3 to 8 months). Bradykinesia was the last to resolve (9 to 12 months). In the other two patients, parkinsonian features were recovering when last seen after 2 months of acute illness. A detailed account of selected patients follows.

Patient 1.

A 14-year-old girl developed a fever of 104 °F with severe headache and body ache. There was no seizure, vomiting, or unconsciousness. Four days after the fever, she developed hypophonic speech and restlessness. After 2 days, her relatives noticed stiffness in her body and slowing in all body movements. She moved with short steps and forward stoop. She preferred not to speak most of the time and, on great provocation, spoke in a low volume slurred speech, which remained fluent. On examination, the patient was conscious, well oriented, and cooperative. She had masklike face, drooling of saliva, and parkinsonian gait. She was restless, anxious, and depressed. She preferred to constantly move around whenever left unattended. Her glabellar-tap sign and palmomental reflex were positive. Her movements were extremely slow. Her limbs had cogwheel rigidity that was more marked at wrist, ankle, and forearm supination/pronation. She had normal power, normal deep tendon reflexes, and bilaterally flexor plantar response. Sensory system was normal and cerebellar signs were absent. Her CSF examination revealed normal sugars, 50 mg/dL proteins, and 10 cells/mm3 (all lymphocytes). Serum antibodies against JE virus showed a more than fourfold rise in titers within 12 days. MRI of the brain showed T2 hyperintense lesions confined to substantia nigra in both upper and lower midbrain axial sections. These were hypointense on T1 and of mixed intensity on MT sequence. There was no enhancement on gadolinium contrast injection (figure 1). The patient was followed for 1 year. Her irritability and tendency to move around fully recovered within 1 month. She was still speaking less and in a monotonous low volume voice. Her gait became typically parkinsonian. Depression, drooling of saliva, hypokinesia, and cogwheel rigidity persisted. Examination done between 6 months and 1 year showed gradual improvement in all her parkinsonian features. At 1 year, she had no neurologic deficit.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. T2 (A), T1 (B), magnetization transfer (MT)–T1 (C), and postcontrast MT–T1 (D) weighted MRI in the axial plane through the midbrain in a patient with Japanese encephalitis show selective lesions in the substantia nigra that are bilateral but asymmetric. The lesions appear hyperintense on T2 (arrows), hypointense on T1, and mixed intensity on MT–T1-weighted images. There is no abnormal enhancement on postcontrast MT–T1-weighted image. The rest of the brain did not show any signal abnormality.

Patient 3.

A 7-year-old girl had headache, vomiting, and low grade fever a month before admission. Two days after the onset of illness, the fever became high, and went up to 105 °F along with rigors. The fever lasted 6 days, and on the fifth and sixth days of fever, she had alteration of consciousness and dystonic posturing of the neck. She developed focal seizures on the 12th day of her illness for which she was put on carbamazepine. During coma, she had stiffness in her entire body and tremulousness on sitting with support. On regaining consciousness after 20 days, she had slowing of her body movements. She did not attempt to comprehend or speak.

Examination carried out 1 month after the onset of illness revealed a conscious but irritable child who did not respond to verbal commands. She had masking of facial expression, drooling of saliva, positive glabellar-tap sign, opsoclonus, generalized rigidity, and cogwheeling at distal joints. Her movements were extremely slow. There were tremors in both hands, which became typical pill rolling when she was made to stand with support. Her CSF showed 70 mg/dL sugars, 60 mg/dL proteins, and 20 cells/mm3 (all lymphocytes). Titers against JE virus were 1:80 and 1:640 in acute and convalescent sera. MRI brain showed hyperintense lesion in the substantia nigra on T2-weighted image (figure 2A), which was hypointense on T1 and of mixed intensity on MT sequence. There was no contrast enhancement (figure 2B). Two months later, she was still mute, with saliva drooling from the side of her mouth. She walked with forward stoop, pill rolling tremors, and bradykinesia.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Axial MRI through midbrain in a patient with Japanese encephalitis shows T2 hyperintensities (arrows) in the substantia nigra (A). These lesions were hypointense on T1 and of mixed intensity on magnetization transfer (MT)–T1-weighted images. There was no enhancement on postcontrast MT–T1 image (B). Imaging of the rest of the brain showed no abnormal finding.

Patient 5.

A 16-year-old boy had a high-grade fever of 105 °F along with rigors, headache, and vomiting. The prodromal symptoms subsided in 5 days. Over the next week, he gradually stopped speaking and was not responsive to verbal commands. He had a dazed look and stiffness in his body. His movements also became slow. He remained conscious throughout the illness and did not experience seizures. Examination revealed a mute patient with drooling of saliva and a staring look. His spontaneous eye movements were restricted in all directions. Response to verbal commands was absent. Palmo-mental reflex and upbeating nystagmus were present. He had lead pipe rigidity in all four limbs. Minimal cogwheeling was observed at wrist, ankle, and pronation/supination of forearm. There was no pyramidal tract sign or cerebellar sign. His CSF examination showed 68 mg/dL sugars, 70 mg/dL proteins, and 80 cells/mm3 (all lymphocytes). CSF cultures were negative for pyogenic and tubercular infections. Blood PCR for herpes simplex and measles viruses was negative. Paired sera (1 week apart) showed rising titers for JE (first serum, 1:20; convalescent serum, 1:80). MRI showed symmetric lesions in the midbrain confined mainly to substantia nigra (figure 3). The lesions were hyperintense on T2- and hypointense on T1-weighted images. There was no lesion elsewhere in the brain, including thalamus.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. T2-weighted axial MRI through the midbrain shows selective hyperintensities (arrow) in the substantia nigra in a patient with Japanese encephalitis.

Examination after 10 days of admission revealed a conscious patient who could comprehend verbal commands. He had masking of face and mutism. His nystagmus and palmo-mental reflex improved. Glabellar-tap habituation was absent. He could move his eyes in all directions. Upgaze and downgaze were normal. He still had drooling of saliva. The most prominent finding was lead pipe rigidity with occasional cogwheeling at distal joints. He walked with forward stoop, generalized bradykinesia, and pill rolling tremors. The tremors responded to anticholinergic agents. Most of the other parkinsonian features responded mildly to levodopa, and the response was better but still incomplete when amantadine was added.

Initial 6 months’ follow-up revealed increase in alertness, improvement in comprehension, and decrease in drooling. Speech became fluent but continued to be monotonous and slurred. Tremors that symptomatically improved with trihexiphenedyl remained improved on gradual withdrawal of the drug. Other parkinsonian features were still present at 6 months and were only partially responsive to levodopa and amantadine. All parkinsonian features gradually improved in the next 6 months, so much so that 1 year from acute illness, he did not require any medication.

Discussion.

The five cases described here had evidence of infection with JE virus. All belonged to an endemic zone in the northeastern region of the Uttar Pradesh province of India.11 This region borders southwestern Nepal, where JE is quite prevalent.15 All the patients had prodromal symptoms and CSF findings compatible with viral encephalitis. Predominant extrapyramidal signs during convalescence were suggestive of JE.16 PCR study for herpes simplex and measles encephalitis was negative in all patients. The diagnosis was confirmed in four of our five patients by HI test, which demonstrated significant rise in titers against JE virus in convalescent serum as compared with acute serum. Although the rise in HI antibody titers in three of our patients was less than the somewhat arbitrary criterion of fourfold rise, it was well within the range observed in different studies on JE from this region.3,14 One patient (Patient 2 in the table) had very high initial titers as his acute phase was already over by the time he was first attended by us. His first as well as second blood sample, withdrawn 10 days apart, showed very high HI titers without showing a rising trend as both of his blood samples represented the convalescent phase. His diagnosis was supported by studying the third blood sample after 10 months of acute illness, which showed considerable fall in the titers. This suggested that his initial rise in HI titers was not related to his basic immunity against JE but due to acute infection with JE virus. None of our patients was vaccinated against JE as the vaccine is not in general use in India.

JE is usually a diffuse meningoencephalitis that involves several areas of the CNS.7,16,17 Autopsy studies have shown involvement of grey as well as white matter of the cerebral hemispheres, thalamus, brainstem, basal ganglia, cerebellum, and spinal cord.4 Reported pathologic features are focal capillary congestion, edema, punched out necrolytic areas, small capillary hemorrhages, perivascular mononuclear infiltration, and necrosis.4,18 These pathologic findings, however, have been observed in severe cases who died of JE. In relatively mild patients who recover, CT and MRI studies have shown widespread lesions distributed in different parts of CNS.17,19 In most of these studies, thalamic involvement has been emphasized as the most important finding. The five cases described here had no thalamic involvement and lesions were confined to substantia nigra in the midbrain region. This suggests that thalamic involvement, although extremely common, is not essential for MR diagnosis of JE. Involvement of midbrain is perhaps equally important and may occasionally be the exclusive site of lesion. MRI evidence of isolated lesions in the substantia nigra, as described here, has never been documented in JE. However, several recent reports include substantia nigra as one of the many sites of involvement in JE. In one autopsy study on human brains, JE viral antigen was immunocytochemically localized to thalamus, hippocampus, substantia nigra, and medulla oblongata.20 A similar study on JE virus–infected mice demonstrated viral antigen mainly in substantia nigra, striatum, cerebral cortex, hippocampus, diencephalon, and other parts of mesencephalon.21 In another human autopsy study, lesions were found in thalamus, substantia nigra, and Ammon’s horn.18 In this study, the lesions in the substantia nigra were mainly in the middle parts of zona compacta. There are anecdotal case reports on JE in which MRI showed lesions in the substantia nigra along with other common sites such as thalamus, hippocampus, globus pallidus, and cerebral white matter.10,22

The current description of JE patients with isolated lesions in the substantia nigra has great significance in view of the good correlation with the clinical syndrome in which parkinsonian features predominated. Such selective lesions have been demonstrated with toxins such as MPTP. However, the current study demonstrates the capability of a virus to do so. The initial clinical course of the five cases described here indicates affection of the brain beyond substantia nigra, as is evident from the presence of one or more than one of the following: alteration of consciousness, opsoclonus, upbeating nystagmus, restriction of eye movements, and seizures. MRI showed lesions in the substantia nigra and nowhere else in the brain. This suggests that significant lesions were confined to this region alone. This is also evident from the follow-up of these patients who showed early improvement in signs other than parkinsonism. Although parkinsonian features also improved within 1 year, it would require a long-term follow-up of these patients or the experimental studies on animals to know whether mild to moderate virulence of the virus can cause partial damage to cells in the substantia nigra, rendering them vulnerable for early abiotrophy at some later stage of life. The significance of this hypothesis lies in the fact that many people develop subclinical infection in the endemic zone, and the possibility of substantia nigra involvement in some of them (and in few others with only prodromal symptoms) cannot be ruled out. This is relevant in view of the fact that all of our patients had a relatively mild clinical course, involvement of only a very small segment of the brain, and complete clinical recovery. They had no or minimal alteration of consciousness, from which they recovered quickly. There were no signs of raised intracranial pressure, no MRI evidence of hemorrhage within the lesions, and no gadolinium enhancement. The vital functions remained normal throughout their illness. Also, the various types of movement disorders described with widespread thalamic and basal ganglia lesions in JE were absent in these patients except for the parkinsonian features.

The parkinsonian syndrome observed in our patients correlates well with MRI evidence of selective involvement of substantia nigra. This observation is also in accordance with experimental evidence from JE virus–infected Fischer rats that suggests decrease in tyrosine hydroxylase-positive neurons in bilateral substantia nigra and resultant decrease in dopamine concentrations in the striatum.9

Several viruses can involve substantia nigra with or without involvement of other parts of the brain. The damage caused by these viruses could be due to release of cytokines from the virus-infected cells or due to direct invasion of substantia nigra by the virus. In one study, 50% of HIV patients with parkinsonism had typical akinetic parkinsonian features that could not be attributed to concurrent use of neuroleptic agents.23 In another study, the number of neuronal cell bodies in pars compacta were 25% lower in AIDS patients despite no direct viral invasion.24 Although these patients had no extrapyramidal syndrome, the subclinical nigral degeneration was implicated in the heightened susceptibility of some AIDS patients to drug-induced parkinsonism.24 Parkinsonism due to lesions in the substantia nigra is also reported with encephalitic illness similar to that of encephalitis lethargica of von Economo’s type.25-27 In one study, fluorodopa PET showed a significant bilateral reduction of tracer accumulation in both putamen similar to that observed in patients with idiopathic PD.27 These findings were suggestive of limited lesions in the dopaminergic neurons of the substantia nigra even though the clinical syndrome also included axial dystonia and stereotyped abnormal movements along with severe parkinsonism.

  • Received November 16, 1998.
  • Accepted June 20, 1999.

References

  1. ↵
    Umenai T, Krzysko R, Baktimirov TA, Assaad FA. Japanese encephalitis: current worldwide status. Bull WHO 1985;63:625–631.
    OpenUrlPubMed
  2. ↵
    Burke DS, Nisalak A, Ussery MA, et al. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 1985;151:1093–1099.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Sharma S, Mathur A, Prakash V, Kulshreshtha R, Kumar R, Chaturvedi UC. Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children. Clin Exp Immunol 1991;85:85–89.
    OpenUrlPubMed
  4. ↵
    Shanker SK, Vasudev Rao T, Mruthyunjayanna BP, Gouri-Devi M, Deshpande DH. Autopsy study of brains during an epidemic of Japanese encephalitis in Karnataka. Ind J Med Res 1983;78:431–440.
    OpenUrlPubMed
  5. ↵
    Johnson RT, Burke DS, Elwell M, et al. Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 1985;18:567–573.
    OpenUrlCrossRefPubMed
  6. ↵
    Zimmerman HM. The pathology of Japanese B encephalitis. Am J Pathol 1946;22:965–991.
    OpenUrlPubMed
  7. ↵
    Haymaker W, Sabin AB. Topographic distribution of lesions in central nervous system in Japanese B encephalitis. Arch Neurol Psychiatry 1947;57:673–692.
    OpenUrlCrossRefPubMed
  8. ↵
    Dickerson RB, Newton JR, Hansen JE. Diagnosis and immediate prognosis of Japanese B encephalitis. Am J Med 1952;12:277–288.
  9. ↵
    Ogata A, Nagashima K, Yasui K, Matsumura T, Tashiro K. Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus–induced parkinsonism in rats. J Neurol Sci 1998;159:135–139.
    OpenUrlPubMed
  10. ↵
    Ushida M, Fukuda K, Endo S, Okada T. A case of Japanese B encephalitis with lesions of thalamus and substantia nigra revealed by MRI. No To Hattatsu 1998;30:312–316.
    OpenUrlPubMed
  11. ↵
    Ananthanarayan R, Jayram Panikar CK. Textbook of microbiology. Madras:Orient Longman, 1990:512–513.
  12. ↵
    Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination inhibition with arthopod borne-viruses. Am J Trop Med Hyg 1958;7:561–573.
  13. ↵
    Mathur A, Arora KL, Chaturvedi UC. Host defence mechanism against Japanese encephalitis virus infection in mice. J Gen Virol 1983;64:805–812.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Kumar R, Mathur A, Kumar A, Sethi GD, Sharma S, Chaturvedi UC. Virological investigations of acute encephalopathy in India. Arch Dis Child 1990;65:1227–1230.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Wakai S. Scourge of Japanese encephalitis in southwestern Nepal. Lancet 1998;351:759. Letter.
    OpenUrl
  16. ↵
    Bharucha NE, Bharucha EP. Neurology in India. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in clinical practice. Boston:Butterworth-Heinemann, 1991:1925–1941.
  17. ↵
    Shoji H, Hiraki U, Kuwasaki N, Toyomasu T, Kaji M, Okudera T. Japanese encephalitis in the Kurume region of Japan: CT and MRI findings. J Neurol 1989;236:255–259.
    OpenUrlCrossRefPubMed
  18. ↵
    Ishii T, Matsushita M, Hamada S. Characteristic residual neuropathological features of Japanese B encephalitis. Acta Neuropathol 1977;38:181–186.
    OpenUrlCrossRefPubMed
  19. ↵
    Shoji H, Murakami T, Murai I, et al. Follow up study by CT and MRI in three cases of Japanese encephalitis. Neuroradiology 1990;32:215–219.
    OpenUrlCrossRefPubMed
  20. ↵
    Desai A, Shanker SK, Ravi V, Chandramuki A, Gouri-Devi M. Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol 1995;89:368–373.
    OpenUrlCrossRefPubMed
  21. ↵
    Yamashita Y, Ito T, Hashimoto I, Ohyama A, Kuriyama K. Changes in cerebral level of monoamines by Japanese encephalitis viral infection. Uirusu 1989;39:47–54.
    OpenUrlPubMed
  22. ↵
    Matsumura R, Nakamura T, Sugata T, Mano Y, Takayanagi T. A case of Japanese encephalitis demonstrating characteristic changes in MRI. Rinsho Shinkeigaku 1991;8:869–871.
    OpenUrl
  23. ↵
    Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord 1998;13:684–689.
    OpenUrlCrossRefPubMed
  24. ↵
    Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1991;82:39–44.
    OpenUrlCrossRefPubMed
  25. ↵
    Cheyette SR, Cummings JL. Encephalitis lethargica: lessons for contemporary neuropsychiatry. J Neuropsychiatr Clin Neurosci 1995;7:125–134.
    OpenUrlPubMed
  26. Mellon AF, Appleton RE, Gardner-Medwin D, Aynsley-Green A. Encephalitis lethargica-like illness in a five-year-old. Dev Med Child Neurol 1991;33:158–161.
    OpenUrlPubMed
  27. ↵
    Picard F, de Saint-Martin A, Salmon E, Hirsch E, Marescaux C. Postencephalitic stereotyped involuntary movements responsive to l-dopa. Mov Disord 1996;11:567–570.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Patients and methods.
    • Results.
    • Discussion.
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Brief Communications
    Persistent movement disorders following Japanese encephalitis
    U. A. Murgod, U. B. Muthane, V. Ravi et al.
    Neurology, December 26, 2001
  • Articles
    Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI
    M. Filippi, G. Iannucci, C. Tortorella et al.
    Neurology, February 01, 1999
  • Articles
    Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI
    B. Benedetti, A. Charil, M. Rovaris et al.
    Neurology, February 27, 2006
  • Correspondence
    Akihiko Ogata, Kunio Tashiro et al.
    Neurology, August 22, 2000
Neurology: 100 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise